Coagulopathy in α‐galactosyl transferase knockout pulmonary xenotransplants

Bush EL, Barbas AS, Holzknecht ZE, Byrne GW, McGregor CG, Parker W, Duane Davis R, Lin SS. Coagulopathy in α‐galactosyl transferase knockout pulmonary xenotransplants. Xenotransplantation 2011; 18: 6–13. © 2011 John Wiley & Sons A/S.

[1]  E. Klein,et al.  Impact of Thrombocytopenia on Survival of Baboons with Genetically Modified Pig Liver Transplants: Clinical Relevance , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  M. Okabe,et al.  Complement regulation in the GalT KO era , 2010, Xenotransplantation.

[3]  A. D'apice,et al.  Xenotransplantation: the next generation of engineered animals. , 2009, Transplant immunology.

[4]  D. Cooper,et al.  Xenotransplantation of solid organs in the pig-to-primate model. , 2009, Transplant immunology.

[5]  R. Pierson,et al.  The Innate Immune Response and Activation of Coagulation in α1,3-Galactosyltransferase Gene-Knockout Xenograft Recipients , 2009, Transplantation.

[6]  A. Billiau,et al.  Xenotransplantation: where are we in 2008? , 2008, Kidney international.

[7]  H. Tazelaar,et al.  Proteomic identification of non‐Gal antibody targets after pig‐to‐primate cardiac xenotransplantation , 2008, Xenotransplantation.

[8]  Li Bingqian,et al.  Transgenic mice designed to express human α-1,2-fucosyltransferase in combination of human DAF and CD59 to avoid xenograft rejection , 2008 .

[9]  I. Pipinos,et al.  P10. Mitochondrial Defects and Oxidative Damage in Patients With Peripheral Arterial Disease , 2008 .

[10]  R. Pierson,et al.  P17. Administration of Clodronate Confers Added Protection Against HALR , 2008 .

[11]  H. Kang,et al.  Pre‐treatment of porcine pulmonary xenograft with desmopressin: a novel strategy to attenuate platelet activation and systemic intravascular coagulation in an ex‐vivo model of swine‐to‐human pulmonary xenotransplantation , 2008, Xenotransplantation.

[12]  Bing-qian Liu,et al.  Transgenic mice designed to express human α-1,2-fucosyltransferase in combination of human DAF and CD59 to avoid xenograft rejection , 2008, Science in China Series C: Life Sciences.

[13]  R. Pierson,et al.  Life-supporting function of genetically modified swine lungs in baboons. , 2007, The Journal of thoracic and cardiovascular surgery.

[14]  G. Gonzalez-Stawinski,et al.  Prolonged Function of Macrophage, von Willebrand Factor‐Deficient Porcine Pulmonary Xenografts , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  G. Gonzalez-Stawinski,et al.  Depletion of Pulmonary Intravascular Macrophages Prevents Hyperacute Pulmonary Xenograft Dysfunction , 2006, Transplantation.

[16]  Keiji Oi,et al.  Cardiac xenotransplantation : Recent preclinical progress with 3-month median survival , 2005 .

[17]  T. Shigehisa,et al.  Production of α1,3‐galactosyltransferase gene knockout pigs expressing both human decay‐accelerating factor and N‐acetylglucosaminyltransferase III , 2005 .

[18]  D. Sachs,et al.  Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue , 2005, Nature Medicine.

[19]  N. Mueller,et al.  Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience , 2005, Nature Medicine.

[20]  M. Olausson,et al.  Prevention of acute lung injury in swine: depletion of pulmonary intravascular macrophages using liposomal clodronate. , 2003, The Journal of surgical research.

[21]  J. Platt,et al.  Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation. , 2002, Transplantation.

[22]  H. Schuurman,et al.  Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors , 2002, Transplantation.

[23]  T. Shigehisa,et al.  Transgenic pigs expressing human decay‐accelerating factor regulated by porcine MCP gene promoter , 2002, Molecular reproduction and development.

[24]  B. N. Day,et al.  Production of α-1,3-Galactosyltransferase Knockout Pigs by Nuclear Transfer Cloning , 2002, Science.

[25]  H. Hauser,et al.  CYTOMEGALOVIRUS EARLY PROMOTER INDUCED EXPRESSION OF hCD59 IN PORCINE ORGANS PROVIDES PROTECTION AGAINST HYPERACUTE REJECTION1 , 2001, Transplantation.

[26]  T. Shigehisa,et al.  Remodeling of the Major Pig Xenoantigen by N-Acetylglucosaminyltransferase III in Transgenic Pig* , 2001, The Journal of Biological Chemistry.

[27]  J. Platt,et al.  A HUMAN CD46 TRANSGENIC PIG MODEL SYSTEM FOR THE STUDY OF DISCORDANT XENOTRANSPLANTATION , 2001, Transplantation.

[28]  J. Platt,et al.  The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants. , 2000, The Journal of thoracic and cardiovascular surgery.

[29]  A. B. Stewart,et al.  Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. , 2000, Transplantation.

[30]  J. Platt,et al.  Total respiratory support from swine lungs in primate recipients. , 1998, The Journal of thoracic and cardiovascular surgery.

[31]  J. Platt,et al.  Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. , 1997, Transplantation.